Discovery of triterpenoids as reversible inhibitors of α/β-hydrolase domain containing 12 (ABHD12).
<h4>Background</h4>α/β-Hydrolase domain containing (ABHD)12 is a recently discovered serine hydrolase that acts in vivo as a lysophospholipase for lysophosphatidylserine. Dysfunctional ABHD12 has been linked to the rare neurodegenerative disorder called PHARC (polyneuropathy, hearing los...
Guardado en:
Autores principales: | Teija Parkkari, Raisa Haavikko, Tuomo Laitinen, Dina Navia-Paldanius, Roosa Rytilahti, Miia Vaara, Marko Lehtonen, Sami Alakurtti, Jari Yli-Kauhaluoma, Tapio Nevalainen, Juha R Savinainen, Jarmo T Laitinen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f7600b4b8e944d0bb49648130289d3b2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biochemical and pharmacological characterization of the human lymphocyte antigen B-associated transcript 5 (BAT5/ABHD16A).
por: Juha R Savinainen, et al.
Publicado: (2014) -
Selective hepatitis B and D virus entry inhibitors from the group of pentacyclic lupane-type betulin-derived triterpenoids
por: Michael Kirstgen, et al.
Publicado: (2020) -
ABHD4-dependent developmental anoikis safeguards the embryonic brain
por: Zsófia I. László, et al.
Publicado: (2020) -
Exploring Arts & Health Ethics and Education: Summaries of two online Nordic Arts & Health Research Network meetings
por: Liisa Laitinen
Publicado: (2021) -
Macrophage ABHD5 promotes colorectal cancer growth by suppressing spermidine production by SRM
por: Hongming Miao, et al.
Publicado: (2016)